Markel Reinsurance: Alterra Capital Case Study
Former Resinsurance Claims Manager at Alterra Capital Holdings
inpractise.com/articles/markel-reinsurance-alterra-capital-case-study
Markel Reinsurance: Alterra Capital Case Study(June 17, 2024)
Former Resinsurance Claims Manager at Alterra Capital Holdings
Interview Transcript
This is a snippet of the transcript, sign up to read more.
On the reinsurance side, what type of premiums have you seen these companies move into or out of?
If you're utilizing this model, it's better suited for long-tail scenarios, where payouts are not immediate but predictable. This is typical for sectors like life reinsurance. Markel, for instance, doesn't deal in life reinsurance at all, which is surprising given the significant amount they still have on their books from the acquisition of Max Re. Initially, Alterra, known as Max Re, engaged heavily in reinsurance deals for life insurance because it's very predictable. You generally know the annual mortality rates and the approximate payouts. Additionally, life reinsurance isn't significantly impacted by natural disasters like hurricanes or earthquakes, though there are some effects. The payouts are also deferred over a long period.
This is a snippet of the transcript, sign up to read more.
Related Content
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.